Scientists in China have developed a two-antibody cocktail to treat respiratory syncytial virus, or RSV, that in laboratory ...
A multimillion-pound industry has sprung up promising it can detect sensitivities to certain ingredients with a simple remote finger prick test. But the results can be misleading – and even dangerous ...
San Antonio scientists are gearing up to put a lab-made monoclonal antibody called mAb 77 to the test in juvenile rhesus ...
The CDC has paused diagnostic testing for more than two dozen infectious diseases —including rabies and pox viruses — ...
Morning Overview on MSN
2-antibody RSV cocktail aims to block resistance as the virus evolves
Every winter, respiratory syncytial virus sends tens of thousands of U.S. infants to the hospital, filling pediatric ICU beds ...
A new blood test combined with a standardized questionnaire and artificial intelligence may transform the way leprosy is ...
Serologic testing for core vaccine antibodies is becoming more common in everyday veterinary practice, yet a few persistent ...
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to ...
With CDSCO restricting vaccine and biologic testing to government labs, experts weigh the benefits of rigorous control ...
Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results